The α 4 β 1 (VLA-4, CD49d/CD29) integrin is an adhesion receptor involved in the interaction of lymphocytes, dendritic cells and stem cells with extracellular matrix and endothelial cells. This and other integrins have the ability to regulate their affinity for ligands through a process termed "inside-out" signaling that affects cell adhesion avidity. Several mechanisms are known to regulate integrin affinity and conformation: conformation changes induced by separation of the C-tails, divalent ions and reducing agents. Recently, we described a fluorescent LDV-containing small molecule, which was used to monitor VLA-4 affinity changes on live cells. Using the same molecule, we also developed a FRET based assay to probe the "switchblade-like" opening of VLA-4 upon activation. Here we have investigated the effect of reducing agents on the affinity and conformational state of the VLA-4 integrin simultaneously with cell activation initiated by "inside-out" signaling through G protein-coupled receptors or Mn 2+ on live cells in "real-time".
Summary
The α 4 β 1 (VLA-4, CD49d/CD29) integrin is an adhesion receptor involved in the interaction of lymphocytes, dendritic cells and stem cells with extracellular matrix and endothelial cells. This and other integrins have the ability to regulate their affinity for ligands through a process termed "inside-out" signaling that affects cell adhesion avidity. Several mechanisms are known to regulate integrin affinity and conformation: conformation changes induced by separation of the C-tails, divalent ions and reducing agents. Recently, we described a fluorescent LDV-containing small molecule, which was used to monitor VLA-4 affinity changes on live cells. Using the same molecule, we also developed a FRET based assay to probe the "switchblade-like" opening of VLA-4 upon activation. Here we have investigated the effect of reducing agents on the affinity and conformational state of the VLA-4 integrin simultaneously with cell activation initiated by "inside-out" signaling through G protein-coupled receptors or Mn 2+ on live cells in "real-time".
We found that reducing agents (DTT and DMPS) induced multiple states of high affinity of VLA-4, where the affinity change was accompanied by an extension of the integrin molecule.
Bacitracin, an inhibitor of reductive function of the plasma membrane diminished the effect of DTT but had no effect on the "inside-out" signaling. Based on this result and differences in the kinetics of integrin activation we conclude that conformational activation of VLA-4 by "insideout" signaling is independent of and additive to the reduction-regulated integrin activation.
Introduction
activation we concluded that the activation of VLA-4 by "inside-out" signaling is independent of activation by reducing agents. was from Molecular Probes Eugene, OR). All restriction enzymes were purchased from New England BioLab (Beverly, MA). All other reagents were from Sigma (St. Louis, MO).
Experimental Procedures
Materials
Cell Lines and Transfectant Construct.
The human monoblastoid cell line U937 was purchased from ATCC (Rockville, MD). Site-directed mutants of formyl peptide receptor (FPR) in U937 cells were prepared as described (34) . High expressors were selected using the MoFlo Flow Cytometer, Cytomation, Inc., (Fort Collins, CO). Cells were grown at 37 o C in a humidified atmosphere of 5% CO 2 and 95% air in RPMI 1640 (supplemented with 2 mM L-glutamine, 100 units/mL penicillin, 100 µg/mL streptomycin, 10 mM HEPES, pH 7.4, and 10% heat inactivated fetal bovine serum), then harvested and resuspended in 1 ml of HEPES buffer (110 mM NaCl, 10 mM KCI, 10 mM glucose, 1 mM MgCI 2 , and 30 mM HEPES, pH 7. C. Then, data were acquired for 30-120 s to establish a baseline and DTT (3 mM), fMLFF (100 nM), or ATP (1 µM) was added. Acquisition was re-established, and data were acquired continuously for up to 1000 s. The concentration of the LDV-FITC containing small molecule chosen for the experiments (4 nM) is below the dissociation constant (Kd) for the binding to the resting (low affinity) VLA-4 (Kd ~ 12 nM), and above the Kd for the physiologically activated receptor (high affinity) (Kd ~ 1-2 nM) (31) . Therefore, the transition from the low affinity to the high affinity receptor state leads to the increased binding of the probe (from ~ 25 % to ~ 70-80 %. of receptor occupancy respectively), which is detected as an increase in the mean channel fluorescence (MCF). For dissociation kinetic measurements, cell samples were preincubated with the fluorescent ligand (4-10 nM), treated with excess unlabeled LDV containing small molecule (2 µM) and the dissociation of the fluorescent molecule was followed.
The resulting data were converted to mean channel fluorescence versus time using FCSQuery software developed by Bruce Edwards.
Cell Pretreatement with Bacitracin. U937 cells were preincubated on ice for 1.5 h with 1 mM bacitracin. Prior to the experiment 4 nM LDV-FITC was added and cells were incubated at 37 o C for an additional 15 min. Data were acquired with the flow cytometer for 30 sec to establish a baseline. Then DTT (3 mM), fMLFF (100 nM), or ATP (1 µM) was added. For dissociation experiments, cells were preincubated with bacitracin and LDV-FITC as described above and treated with excess unlabeled LDV containing small molecule (2 µM). Then the dissociation of the fluorescent molecule was followed.
FRET Detection of the Integrin Conformational Activation. The fluorescence resonance energy transfer (FRET) assay used a peptide donor (LDV-FITC, which specifically binds to the α 4 -integrin headgroup) and octadecyl rhodamine B acceptors incorporated into the plasma membrane previously described in detail in (32) . Briefly, U937 cells were preincubated with 50-100 nM LDV-FITC to saturate low affinity sites of the integrin in HEPES buffer (110 mM NaCl, 10 mM KCl, 10 mM glucose, 1 mM MgCl 2 and 30 mM HEPES, pH 7. The quenching curves generated using the following procedure characterize the distance of closest approach between the integrin headgroup and the surface lipid membrane as was shown previously (32) . For "real-time" FRET experiments, U937 cells were stably transfected with the by guest on September 1, 2017 http://www.jbc.org/ Downloaded from wild type or the non-desensitizing mutant (∆ST) of the formyl peptide receptor (35;36) . The U937 cells were preincubated with 50-100 nM LDV-FITC in HHB buffer containing 1.5 mM CaCl 2 and 1 mM MgCl 2 at 37 o C. Samples were analyzed for 60-120 s to establish a baseline, and then saturating R18 (10 µM final) was added to yield maximal quenching. 1 min after R18 was added, fMLFF peptide (0.1 µM), ATP (1 µM), or DTT (3 mM) was added. FACS acquisition was reestablished, after a 5-10 s gap. The cells were also tested using low (3-5 nM) concentration of LDV-FITC to determine the affinity change as described above.
Statistical Analysis. Curve fits and statistics were performed using GraphPad Prism (San Diego, CA). Mean values are presented in Table I and Figures. Each experiment was repeated three times. The experimental curves represent the mean of two independent runs. Standard error of the mean was calculated using GraphPad Prism (GraphPad Software Inc.).
Results
Reducing agents generate multiple affinity states of the VLA-4 integrin as detected using fluorescent ligand-Multiple affinity states of VLA-4 have been detected using the LDV-FITC containing molecule in "real-time" in response to activation by divalent cations, activating mAb, or "inside-out" signaling in response to the stimulation of CXCR2, CXCR4, FPR, IgE, and IL-5 receptors (31) . The affinity of the LDV-FITC probe for the integrin varies in parallel with the affinity of a native ligand (VCAM-1). Cell adhesion avidity was found to be strongly dependent on the affinity of the integrin (33;37). Here, we used the same LDV-FITC containing molecule to probe the affinity of VLA-4 on a surface of U937 cells treated with different concentrations of DTT and DMPS. DMPS is known to be a membrane-impermeant reducing agent due to the presence of a charged acidic group. Fig. 1A shows a typical binding and dissociation experiment in which the LDV-FITC molecule was added to a cell suspension after 30 s of stirring. An excess of unlabeled competitor was added 3 min later. By fitting dissociation kinetics to double exponential curves we extracted rate constants corresponding to states of different affinity (Table   I) . In all experiments, with the exception of untreated cells, a combination of high and low affinity state receptors was detected (Fig. 1A , B and C). For untreated cells only a single exponential fit was needed, and a k off ~ 0.06-0.1 s -1 was obtained. This off-rate corresponds to the resting receptor state (31) . In addition, a resting state was detected on cells treated with low concentrations of reducing agents (300 µM DTT and 1 to 20 mM DMPS) ( Table I ).
Changes in VLA-4 affinity were strongly dose dependent and fits required at least two dissociation rates. Under the strongest reducing conditions (3mM DTT), the dissociation could be fit with two rates (0.014/sec and 0.002/sec), or with three rates, resembling the resting, intermediate, and high affinity states. For consistency, all the data were fit with three fixed rates, (Table I ). The progression of quantitatively similar states led to the idea that a sequential reduction of each of the disulfide bonds generates a distinctive conformation of the molecule (Fig. 1D) .
Kinetics of the affinity changes induced by Mn

2+
and DTT in "real-time" -Next, "real- Fig. 2A) . Next, when the two stimuli were added together biphasic binding kinetics were observed. A rapid binding phase (60-120 s) that resembles "Mn 2+ alone" curve was followed by a slow gradual signal increase similar to the curve "DTT alone" (Fig. 2A) . Analysis of the dissociation kinetics ( Exposure of disulfides to solvent is a factor that regulates the rate of disulfide reduction by reducing agents. Therefore, we investigated whether a conformational change of the integrin molecule induced by cations affects the response to DTT. We subtracted the curve corresponding to the activation by Mn (Fig. 3D ). Thus, a conformational change facilitates an activation of the integrin by DTT. After desensitization and termination of receptor signaling (after ~ 240 s) integrins returned to their resting affinity (31) , and conformational (32) state. As a result disulfide bonds became less accessible to the reducing agent. After ~240 s the slope of the line (Fig. 3C , open circles) became ~ 0.23. This value corresponds to the resting non-extended molecule (Fig. 3C, triangles, Fig. 3D ). Essentially the same behavior of integrins with a faster kinetics was observed when VLA-4 was activated by ATP through P2Y receptors. P2Y2, and P2Y6 are GPCRs nucleotides receptors constitutively expressed on U937 cells (38) (39) (40) (Supplemental Fig. 1 ).
It is worth noting that the ratio between the two slopes for ""DTT & fMLFF -fMLFF" and "DTT alone" ( Bacitracin diminishes the effect of DTT on integrin activation, but has no effect on the response induced by "inside-out" signaling-Recently, it has been proposed that protein disulfide isomerase (PDI) present on the cell surface participates in the regulation of integrindependent adhesion (17-19;24) , and could be a part of "outside-in" and/or "inside-out" signaling pathways (17). To clarify the role of PDI in the "inside-out" activation of the integrin, we used bacitracin, an inhibitor of reductive function of the plasma membrane (20;41) . Preincubation of U937 cells with 1 mM bacitracin significantly diminished the rate of the DTT-induced activation of the VLA-4 (compare slopes on a Fig. 4A ). On the contrary, no statistically significant inhibition of the "inside-out" integrin activation through FPR or P2Y receptors was detected (Fig. 4 B,C) . Bacitracin had no effect on the integrin affinity of resting cells; the dissociation rate was similar for treated and non-treated cells (k off ~ 0.04 s (Fig. 4D) . Thus, the reductive capacity of the plasma membrane had no effect on VLA-4 activation by intracellular signaling. This result is more consistent with the "mechano-conformational" theory of integrin regulation than with involvement of the reductionrelated mechanisms in the "inside-out" integrin activation.
Fluorescence Resonance Energy Transfer based detection of integrin extension induced
by DTT-A FRET based method was used to detect molecular extension of integrins (32) . The LDV-FITC small molecule was used as a fluorescence donor and R18 incorporated into the membrane as an acceptor. U937 cells were treated with different concentrations of DTT, and divalent ions ( and was defined to be 0 Å separation distance. Thus, the activation of VLA-4 using DTT results in the extension of the integrin, in which the headpiece is moving away from the membrane (Fig. 5C) .
Kinetics of DTT-induced extension, detected using FRET, coincides with the kinetics of
affinity changes -Finally, for a "real-time" FRET based assay (32) cells were preincubated with a large excess of the LDV-FITC small molecule. Next, the fluorescent signal was quenched using R18. Then, cells were activated through different GPCRs or DTT. Addition of DTT induced slow and gradual unquenching of the fluorescence signal (Fig. 6B, triangles) . However, the "inside-out" signaling promoted an instant unquenching that reflects rapid extension of the integrin molecule as was shown previously (32) . Thus, the kinetics of the conformational extension of VLA-4, detected using FRET, were different between "inside-out" signaling and activation by DTT as shown for the affinity change. In contrast, when integrins were activated by reducing agents as shown here, several distinctive affinity states of VLA-4 were detected in the cell population at the same time (Table I ). The kinetics of activation by DTT and the changes in VLA-4 affinity were slow, and were dependent on time and concentration. Longer incubation times at higher concentrations of reducing agents resulted in a larger fraction of high affinity VLA-4. These data differed from integrin activation using divalent ions, where usually only one affinity state was detected. Fits to the dissociation data require one exponential curve (see Fig. 1B and C in (33), (43) ). The VLA-4 activating mechanism may explain the above difference: for quickly diffusing divalent ions at high concentrations (usually 1-3 mM) equilibrium is reached rapidly resulting in a similar state for all the receptors. For the reductive activation involving disulfide-exchange reactions, and, possibly enzymatic reactions catalyzed by PDI (17-19;24), several discrete states of integrin activation occur, presumably, by reducing different numbers of disulfide bonds in different molecules. Fig. 1D shows a hypothetical mechanism that relates the number of reduced disulfides to the conformational state of the VLA-4.
Previously, the rapid interconversion between the resting state and the physiologically activated state was demonstrated using the LDV-FITC small molecule (see Fig.5 in (31) ).
However, in this case, only two affinity states (k off1 ~ 0.06 s -1 , and k off2 ~ 0.01 s -1 ) were detected.
The affinity state generated using the highest concentration of DTT was at least 10 times higher (Table I) , than the physiologically activated receptor. Thus, the magnitude of the affinity changes after reductive activation of VLA-4 was significantly different from the one generated through "inside-out" signaling.
Kinetics of the affinity changes and cell activation -Because it has been recognized that integrin affinity can be regulated by a mechanism related to disulfide bond reduction (17;19;21;24), our goal was to determine whether affinity regulation by DTT could occur on a proper time frame to be physiologically relevant. We found that the kinetics of integrin Fig.1 ). Moreover, knowing that reducing agents generate populations of different affinity receptors, our data support the idea that two different mechanisms result in the state of higher integrin affinity. For "inside-out" signaling it could be separation of C-tails of the α and β subunits, resulting in a large conformational change (7;10-12). For reducing agents it could be an enzymatic mechanism that involves PDI-catalyzed disulfide exchange reactions (17-19;21;24).
To further test this hypothesis we used bacitracin, a drug that is known to inhibit the reductive function of the membrane (20;41).
"Inside-out" signaling and reducing agents -Several ideas connecting "inside-out"
signaling and integrin activation led us to investigate the effect of the bacitracin on the integrin activation induced by DTT simultaneously with the signaling though GPCRs. These include a "DTT-sensitive regulatory element" (21), as well as requirements for PDI enzymatic activity for integrin activation (19) , adhesion (24) , and aggregation (17). We showed that bacitracin reduced the rate of DTT induced conformational activation of the integrin (Fig. 4A ), but had no inhibitory effect on integrin activation by "inside-out" signaling ( Fig. 4B and C) . In fact, bacitracin caused slightly slowed desensitization of the LDV-FITC signal in the case of fMLFF stimulation (Fig. 4B , open circles between 100 s and 300 s). These data suggest that regulation of integrins by reducing agents was essentially independent of "inside-out" signaling whereas the GPCR or Mn 2+ induced conformational change increased the rate of integrin activation by reducing agents (Figs. 2, 3 and Supplemental Fig.1 ). Our data show that the affinity state of VLA-4 generated using membrane permeable and impermeable reducing agents was much higher than the state induced by "inside-out" signaling.
Integrins, three or more independent activating mechanisms -
The kinetics of DTT-induced VLA-4 activation was slow in comparison to GPCR stimulation.
Moreover, the presence of large amounts of reducing agent during cell activation had no significant effect on "inside-out" activation. Bacitracin, had no effect on integrin activation via GPCR signaling, but significantly reduced DTT induced activation. These data suggest that integrin activation by "inside-out" signaling is therefore not associated with disulfide reduction (5;9;12)). The exposure and reduction of disulfides within VLA-4 upon activation (49) is more likely to be a result of conformational rearrangement than the cause of it. For reducing agents, the slow reduction of disulfides was facilitated by the conformational change and the associated extension of VLA-4 that was detected using FRET. In our view, the states produced by disulfide reduction are therefore not physiological, although the affinities observed may represent a continuum of affinities accessible to the flexible VLA-4 molecule and encompass those induced by Mn 2+ , activating antibodies, and molecular stretching (see below).
Regulation of VLA-4 affinity and conformation provide a "catch-bond" mechanism -
Previously we showed a progressive increase in VLA-4 affinity, a decrease in ligand dissociation rate, and an increase in distance of closest approach of the ligand binding site to the membrane as the integrin was activated by divalent ions or GPCRs (31;32) . In this report we used a mechanistically different approach to activate integrins -activation by reducing agents. We found that a progressive decrease in the LDV-FITC dissociation rate was accompanied by extension of the integrin molecule detected using endpoint and "real-time" FRET based assays (Fig. 1, Fig. 5, and Fig. 6 ). A strong correlation between the affinity states of VLA-4 and the degree of the molecular extension support the idea that the conformational change involving VLA-4 extension also affects ligand binding affinity (Fig. 7) . These data provide a novel mechanism accounting for an adhesion "catch bond" (51): a mechanical stretching of a flexible integrin molecule during cell rolling or under shear that would induce a high affinity conformation of the integrin, and result in higher cellular adhesive avidity. Supplemental Figure 1 
